标题
Emerging monoclonal antibodies against Clostridium difficile infection
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 17, Issue 4, Pages 415-427
出版商
Informa UK Limited
发表日期
2017-03-06
DOI
10.1080/14712598.2017.1300655
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clostridium difficile flagella predominantly activate TLR5-linked NF-κB pathway in epithelial cells
- (2016) Jameel Batah et al. ANAEROBE
- Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models
- (2016) J.-F. Bruxelle et al. ANAEROBE
- Virulence factors of Clostridium difficile and their role during infection
- (2016) Claire Janoir ANAEROBE
- Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin
- (2016) Peter Warn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection
- (2016) Diane J. Schmidt et al. Clinical and Vaccine Immunology
- Antibodies to Toxin B Are Protective AgainstClostridium difficileInfection Recurrence
- (2016) Swati B. Gupta et al. CLINICAL INFECTIOUS DISEASES
- Intravenous adenovirus expressing a multi-specific, single-domain antibody neutralizing TcdA and TcdB protects mice fromClostridium difficileinfection
- (2016) Zhiyong Yang et al. Pathogens and Disease
- Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC
- (2016) Chandrabali Ghose et al. Emerging Microbes & Infections
- The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia
- (2016) Carrie A. Cowardin et al. Nature Microbiology
- Characteristics of theClostridium difficilecell envelope and its importance in therapeutics
- (2016) Joseph A. Kirk et al. Microbial Biotechnology
- Recurrent Clostridium difficile infection: From colonization to cure
- (2015) Kelsey Shields et al. ANAEROBE
- Targeting surface-layer proteins with single-domain antibodies: a potential therapeutic approach against Clostridium difficile-associated disease
- (2015) Hiba Kandalaft et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model
- (2015) Natalie G. Anosova et al. Clinical and Vaccine Immunology
- Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies
- (2015) Kasper Krogh Andersen et al. INFECTION AND IMMUNITY
- Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals
- (2015) A. Le Monnier et al. JOURNAL OF HOSPITAL INFECTION
- Burden of Clostridium difficile Infection in the United States
- (2015) Fernanda C. Lessa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selection of Nanobodies that Block the Enzymatic and Cytotoxic Activities of the Binary Clostridium Difficile Toxin CDT
- (2015) Mandy Unger et al. Scientific Reports
- Passive and active immunization strategies against Clostridium difficile infections: State of the art
- (2014) Assaf Mizrahi et al. ANAEROBE
- The role of the humoral immune response to Clostridium difficile toxins A and B in susceptibility to C. difficile infection: A case–control study
- (2014) J. Islam et al. ANAEROBE
- Broad Coverage of Genetically Diverse Strains of Clostridium difficile by Actoxumab and Bezlotoxumab Predicted byIn VitroNeutralization and Epitope Modeling
- (2014) Lorraine D. Hernandez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutational approaches to improve the biophysical properties of human single-domain antibodies
- (2014) Dae Young Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Mechanisms of Protection against Clostridium difficile Infection by the Monoclonal Antitoxin Antibodies Actoxumab and Bezlotoxumab
- (2014) Zhiyong Yang et al. INFECTION AND IMMUNITY
- Toxin-Mediated Paracellular Transport of Antitoxin Antibodies Facilitates Protection against Clostridium difficile Infection
- (2014) Z. Zhang et al. INFECTION AND IMMUNITY
- Mechanism of Action and Epitopes ofClostridium difficileToxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography
- (2014) Peter Orth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Multivalent, Single-Domain Antibody Targeting TcdA and TcdB Prevents Fulminant Clostridium difficile Infection in Mice
- (2014) Zhiyong Yang et al. JOURNAL OF INFECTIOUS DISEASES
- A Novel Secreted Metalloprotease (CD2830) fromClostridium difficileCleaves Specific Proline Sequences in LPXTG Cell Surface Proteins
- (2014) Paul J. Hensbergen et al. MOLECULAR & CELLULAR PROTEOMICS
- A Mixture of Functionally Oligoclonal Humanized Monoclonal Antibodies That Neutralize Clostridium difficile TcdA and TcdB with High Levels ofIn VitroPotency ShowsIn VivoProtection in a Hamster Infection Model
- (2013) Nicola L. Davies et al. Clinical and Vaccine Immunology
- Protective Efficacy Induced by Recombinant Clostridium difficile Toxin Fragments
- (2013) Rosanna Leuzzi et al. INFECTION AND IMMUNITY
- Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B fromClostridium difficile
- (2013) Tomohiko Murase et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Importance of Toxin A, Toxin B, and CDT in Virulence of an Epidemic Clostridium difficile Strain
- (2013) Sarah A. Kuehne et al. JOURNAL OF INFECTIOUS DISEASES
- The Role of Flagella in Clostridium difficile Pathogenesis: Comparison between a Non-Epidemic and an Epidemic Strain
- (2013) Soza T. Baban et al. PLoS One
- Identification of a Novel Zinc Metalloprotease through a Global Analysis of Clostridium difficile Extracellular Proteins
- (2013) Valeria Cafardi et al. PLoS One
- Potent monoclonal antibodies againstClostridium difficiletoxin A elicited by DNA immunization
- (2013) Chunhua Zhang et al. Human Vaccines & Immunotherapeutics
- A Chimeric Toxin Vaccine Protects against Primary and Recurrent Clostridium difficile Infection
- (2012) Haiying Wang et al. INFECTION AND IMMUNITY
- Protection Against Clostridium difficile Infection With Broadly Neutralizing Antitoxin Monoclonal Antibodies
- (2012) Andre J. Marozsan et al. JOURNAL OF INFECTIOUS DISEASES
- A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model
- (2012) Jean Mukherjee et al. PLoS One
- Encapsulation of Cwp84 into pectin beads for oral vaccination against Clostridium difficile
- (2011) Chiara Sandolo et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Immunization of hamsters againstClostridium difficileinfection using the Cwp84 protease as an antigen
- (2011) Séverine Péchiné et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Development and Evaluation of an Ovine Antibody-Based Platform for Treatment of Clostridium difficile Infection
- (2011) April Roberts et al. INFECTION AND IMMUNITY
- Neutralization ofClostridium difficileToxin A with Single-domain Antibodies Targeting the Cell Receptor Binding Domain
- (2011) Greg Hussack et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapeutic potential of egg yolk antibodies for treating Clostridium difficile infection
- (2011) G. L. Mulvey et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Engineered Single-Domain Antibodies with High Protease Resistance and Thermal Stability
- (2011) Greg Hussack et al. PLoS One
- Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT)
- (2011) P. Papatheodorou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of toxin A and toxin B in Clostridium difficile infection
- (2010) Sarah A. Kuehne et al. NATURE
- Treatment with Monoclonal Antibodies againstClostridium difficileToxins
- (2010) Israel Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation
- (2009) M. M. Harmsen et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- New trends in Clostridium difficile virulence and pathogenesis
- (2009) C. Denève et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Toxin B is essential for virulence of Clostridium difficile
- (2009) Dena Lyras et al. NATURE
- Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
- (2009) Brett A. Leav et al. VACCINE
- Immunoreactive cell wall proteins of Clostridium difficile identified by human sera
- (2008) A. Wright et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Structure and mode of action of clostridial glucosylating toxins: the ABCD model
- (2008) Thomas Jank et al. TRENDS IN MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search